Mycoplasma pneumoniae - a national public health perspective

Current Pediatric Reviews

Volumn 9, Issue 4, 2013, Pages 324-333

  Winchell, Jonas M ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

Atypical bacterial pneumonia; CAP; Epidemiology; Mycoplasma pneumoniae

Indexed keywords

MACROLIDE;

ANTIBIOTIC RESISTANCE; BACTERIAL GENOME; BACTERIUM IDENTIFICATION; COMMUNITY ACQUIRED PNEUMONIA; HUMAN; MYCOPLASMA PNEUMONIA; MYCOPLASMA PNEUMONIAE; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; PUBLIC HEALTH SERVICE; REVIEW;

EID: 84891498653     PISSN: 15733963     EISSN: 18756336     Source Type: Journal    
DOI: 10.2174/15733963113099990009     Document Type: Review

References (80)

1. Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev 2004; 17(4): 697-728.
2. Marston BJ, Plouffe JF, File Jr TM, et al. Incidence of communityacquired pneumonia requiring hospitalization. Results of a population-based active surveillance study in Ohio. The Community-Based Pneumoniae Incidence Study Group. Arch Intern Med 97 A. D; 157: 1709-18.
3. Porath A, Schlaeffer F, Lieberman D. The epidemiology of community-acquired pneumonia among hospitalized adults. J Infect 1997; 34(1): 41-8.
4. Block S, Hedrick J, Hammerschlag MR, Cassell GH, Craft JC. Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate. Pediatr Infect Dis J 1995; 14(6): 471-7.
5. Korppi M, Heiskanen-Kosma T, Kleemola M. Incidence of community-acquired pneumonia in children caused by Mycoplasma pneumoniae: Serological results of a prospective, population-based study in primary health care. Respirology 2004; 9(1): 109-14.
6. Layani-Milon MP, Gras I, Valette M, Luciani J, Stagnara J, Aymard M, et al. Incidence of Upper Respiratory Tract Mycoplasma pneumoniae infections among outpatients in Rhone-Alpes, France, during five successive winter periods. J Clin Microbiol 1999; 37(6): 1721-6.
7. Rasmussen JN, Voldstedlund M, Andersen RL, et al. Increased incidence of Mycoplasma pneumoniae infections detected by laboratory-based surveillance in Denmark in 2010. Euro Surveillance 2010; 15(45).
8. Gutierrez F, Masia M, Mirete C, et al. The influence of age and gender on the population-based incidence of community-acquired pneumonia caused by different microbial pathogens. J Infect 2006; 53(3):166.
9. Dorigo-Zetsma JW, Verkooyen RP, Van Helden HP, Van Der Nat H, Van Den Bosch J. Molecular detection of Mycoplasma pneumoniae in adults with community-acquired pneumonia requiring hospitalization. J Clin Microbiol 2001; 39(3): 1184-6.
10. Miyashita N, Ouchi K, Kawasaki K, et al. Mycoplasma pneumoniae pneumonia in the elderly. Med Sci Monit 2008; 14(8): CR387-CR391.
11. Gadsby NJ, Reynolds AJ, McMenamin J, et al. Increased reports of Mycoplasma pneumoniae from laboratories in Scotland in 2010 and 2011-impact of the epidemic in infants. Euro Surveillance 2012 Mar 8;17(10).
12. Principi N, Esposito S. Emerging role of Mycoplasma pneumoniae and Chlamydia pneumoniae in paediatric respiratory-tract infections. Lancet Infect Dis 2001; 1(5): 334-44.
13. Nariai A. Mycoplasma pneumoniae infection in hospitalized children with acute pneumonia under the Mycoplasma epidemic. [Article in Japanese]. Kansenshogaku Zasshi 2004; 78(6): 496-502.
14. Othman N, Isaacs D, Kesson A. Mycoplasma pneumoniae infections in Australian children. J Paediatr Child Health 2005; 41(12): 671.
15. Defilippi A, Silvestri M, Tacchella A, Giacchino R, Melioli G, Di Marco E, et al. Epidemiology and clinical features of Mycoplasma pneumoniae infection in children. Respiratory Medicine 2008 Dec; 102(12): 1762-8.
16. Principi N, Esposito S, Blasi F, Allegra L. Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired lower respiratory tract infections. Clin Infect Dis 2001; 32(9): 1281.
17. Ferwerda A, Moll HA, de Groot R. Respiratory tract infections by Mycoplasma pneumoniae in children: a review of diagnostic and therapeutic measures. Eur J Pediatr 2001; 160(8): 483-91.
18. Kumar S, Maria A, Saigal SR, Maheshwari M. Mycoplasma pneumoniae as a cause of non-resolving pneumonia in a neonate. J Med Microbiol 2010; 59(6): 731.
19. Ursi D, Ursi JP, Ieven M, Docx M, Van Reempts P, Pattyn SR. Congenital pneumonia due to Mycoplasma pneumoniae. Arch Dis Child Fetal Neonatal Ed 1995; 72(2): F118-F120.
20. Golubjatnikov R, Allen VD, Olmos-Blancarte MP, Inhorn SL. Serologic profile of children in a Mexican highland community; prevalence of complement-fixing antibodies to Mycoplasma pneumoniae, respiratory syncytial virus and parainfluenza viruses. Am J Epidemiol 1975; 101(5): 458-64.
21. Joosting AC, Harwin RM, Coppin A, Battaglia P, van der Hoef P. A serological investigation of Mycoplasma pneumoniae infection on the Witwatersrand. S Afr Med J 1976; 50(54): 2134-5.
22. Suhs RH, Feldman HA. Serologic epidemiologic studies with M. pneumoniae. Am J Epidemiol 1966; 83(2): 357-65.
23. Nilsson AC, Björkman P, Persson K. Polymerase chain reaction is superior to serology for the diagnosis of acute Mycoplasma pneumoniae infection and reveals a high rate of persisten infection. BMC Microbiol 2008; 8: 93-100.
24. Foy HM, Grayston J, Kenny G, Alexander E, McMahan R. Epidemiology of Mycoplasma pneumoniae infection in families. JAMA 1966;197(11):859-66.
25. Foy HM, Kenny GE, Marion KC, Allan ID. Long-term epidemiology of infections with Mycoplasma pneumoniae. J Infect Dis 1979; 139(6): 681-7.
26. Lind K, Benzon MW, Jensen S, Clyde W.A. Jr. A seroepidemiological study of Mycoplasma pneumoniae infections in Denmark over the 50-year period 1964 to 1995. Eur J Epidemiol 1997; 13(5): 581.
27. Foy HM. Infections caused by Mycoplasma pneumoniae and possible carrier state in different populations of patients. Clin Infect Dis 1993;17 Suppl 1:S37-S46.
28. Okazaki N, Ohya H, Sasaki T. Mycoplasma pneumoniae isolated from patients with respiratory infection in Kanagawa Prefecture in 1976-2006: emergence of macrolide-resistant strains. Jpn J Infect Dis 2007; 60(5): 325-6.
29. Jacobs E, Vonski M, Oberle K, Opitz O, Pietsch K. Are outbreaks and sporadic respiratory infections by Mycoplasma pneumoniae due to two distinct subtypes? Eur J Clin Microbiol Infect Dis 1996; 15(1): 38-44.
30. Chalker V, Stocki T, Mentasti M, Fleming D, Harrison TG. Increased incidence of Mycoplasma pneumoniae infection in England and Wales in 2010: multiocus variable number tandem repeat analysis typing and macrolide susceptibility. Euro Surveill 2011; 16(19) pii: 19865.
31. Kenri T, Okazaki N, Yamazaki T, et al. Genotyping analysis of Mycoplasma pneumoniae clinical strains in Japan between 1995 and 2005: type shift phenomenon of M. pneumoniae clinical strains. J Med Microbiol 2008; 57(4): 469-75.
32. Walter ND, Grant G, Bandy U, et al. Community outbreak of Mycoplasma pneumoniae Infection: school-based cluster of neurologic disease associated with household transmission of respiratory illness. J Infect Dis 2008; 198: 1365-74.
33. Hyde TB, Gilbert M, Schwartz S, et al. Azithromycin prophylaxis during a hospital outbreak of Mycoplasma pneumoniae pneumonia. J Infect Dis 2001; 183(6): 907-12.
34. Kannan TR, Hardy RD, Coalson JJ, et al. Fatal outcomes in family transmission of Mycoplasma pneumoniae. Clin Infect Dis 2012; 54(2): 225-31.
35. Sliman JA, Metzgar D, Asseff DC, Coon RG, Faix DJ, Lizewski S. Outbreak of acute respiratory disease caused by Mycoplasma pneumoniae on board a deployed U.S. Navy ship. J Clin Microbiol 2009; 47(12): 4121-3.
36. Waites KB, Katz B, Schelonka RL. Mycoplasmas and Ureaplasmas as neonatal pathogens. Clin Microbiol Rev 2005; 18(4): 757-89.
37. Lin WC, Lee PI, Lu CY, et al. Mycoplasma pneumoniae encephalitis in childhood. J Microbiol Immunol Infect 2002; 35(3): 173-8.
38. Smith CB, Friedewald WT, Chanock RM. Shedding of Mycoplasma pneumoniae after tetracycline and erythromycin therapy. N Engl J Med 1967; 276(21): 1172-5.
39. Gnarpe J, Lundbäck, Sundelöf B, Gnarpe H. Prevalence of Mycoplasma pneumoniae in subjectively healthy individuals. Scand J Infect Dis 1992; 24(2): 161-4.
40. Kodani M, Yang G, Conklin LM, et al. Application of TaqMan low-density arrays for simultaneous detection of multiple respiratory pathogens. J Clin Microbiol 2011; 49(6): 2175-82.
41. Winchell JM, Thurman KA, Mitchell SL, Thacker WL, Fields BS. Evaluation of three real-time PCR assays for the detection of Mycoplasma pneumoniae in an outbreak investigation. J Clin Microbiol 2008; 46: 3116-8.
42. Wolff BJ, Thacker WL, Schwartz SB, Winchell JM. Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high resolution melt analysis. Antimicrob Agents Chemother 2008; 52(10): 3542-9.
43. Schwartz SB, Thurman KA, Mitchell SL, Wolff BJ, Winchell JM. Genotyping of Mycoplasma pneumoniae isolates using real-time PCR and high-resolution melt analysis. Clin Microbiol Infect 2009; 15(8): 756-62.
44. Schwartz SB, Mitchell SL, Thurman KA, Wolff BJ, Winchell JM. Identification of P1 variants of Mycoplasma pneumoniae by use of high resolution melt analysis. J Clin Microbiol 2009; 47(12): 4117-20.
45. Degrange S, Cazanave C, Charron A, Renaudin H, Bebear C, Bebear CM. Development of Multiple-Locus Variable-Number Tandem-Repeat Analysis for the molecular typing of Mycoplasma pneumoniae. J Clin Microbiol 2009; 47 (4): 914-23
46. Loens K, Goossens H, Ieven M. Acute respiratory infection due to Mycoplasma pneumoniae: current status of diagnostic methods. Eur J Clin Microbiol Infect Dis 2010; 29(9): 1055-69.
47. Thurman KA, Walter ND, Schwartz SB, et al. Comparison of laboratory diagnostic procedures for detection of Mycoplasma pneumoniae in community outbreaks. Clin Infect Dis 2008; 48: 1244-9.
48. Klausner JD, Passaro D, Rosenberg J, et al. Enhanced control of an outbreak of Mycoplasma pneumoniae pneumonia with azithromycin prophylaxis. J Infect Dis 1998; 177(1): 161-6.
49. Waites KB, Atkinson TP. The role of Mycoplasma in upper respiratory infections. Curr Infect Dis Rep 2009; 11(3): 198-206.
50. Kenri T, Taniguchi R, Sasaki Y, et al. Identification of a new variable sequence in the P1 cytadhesin gene of Mycoplasma pneumoniae: evidence for the generation of antigenic variation by DNA recombination between repetitive sequences. Infect Immun 1999; 67(9): 4557-62.
51. Dumke R, Catrien I, Pirkl E, Herrmann R, Jacobs E. Subtyping of Mycoplasma pneumoniae isolates based on extended genome sequencing and on expression profiles. Int J Med Microbiol 2003; 292(7-8): 513-25.
52. Dorigo-Zetsma JW, Wilbrink B, Dankert J, Zaat SA. Mycoplasma pneumoniae P1 type 1-and type 2-specific sequences within the P1 cytadhesin gene of individual strains. Infect Immun 2001; 69(9): 5612-8.
53. Dorigo-Zetsma JW, Dankert J, Zaat SA. Genotyping of Mycoplasma pneumoniae clinical isolates reveals eight P1 subtypes within two genomic groups. J Clin Microbiol 2000; 38(3): 965-70.
54. Dumke RSNJE. Characterisation of subtype-and variant-specific antigen regions of the P1 adhesin of Mycoplasma pneumoniae. Int J Med Microbiol 2008; 298(5-6): 483-91.
55. Dumke RCIHRJE. Preference, adaptation and survival of Mycoplasma pneumoniae subtypes in an animal model. Int J Med Microbiol 2004; 294(2-3): 149-55.
56. Pereyre S, Charron A, Renaudin H, Bébéar C, Bébéar CM. First report of macrolide-resistant strains and description of a novel nucleotide sequence variation in the P1 adhesin gene in Mycoplasma pneumoniae clinical strains isolated in France over 12 years. J Clin Microbiol 2007; 45(11): 3534-9.
57. Martinez MA, Ruiz M, Zunino E, Luchsinger V, Aguirre R, Avendano LF. Identification of P1 types and variants of Mycoplasma pneumoniae during an epidemic in Chile. J Med Microbiol 2010; 59(8): 925-9.
58. Sasaki T, Kenri T, Okazaki N, et al. Epidemiological study of Mycoplasma pneumoniae infections in Japan based on PCRrestriction fragment length polymorphism of the P1 cytadhesin gene. J Clin Microbiol 1996; 34(2): 447-9.
59. Dumke R, Luck PC, Noppen C, et al. Culture-independent molecular subtyping of Mycoplasma pneumoniae in clinical samples. J Clin Microbiol 2006; 44(7): 2567-70.
60. Spuesens EBM, Oduber M, Hoogenboezem T, et al. Sequence variations in RepMP2/3 and RepMP4 elements reveal intragenomic homologous DNA recombination events in Mycoplasma pneumoniae. Microbiology 2009; 155(7): 2182-96.
61. Spuesens EBM, van de Kreeke N, Estevao S, et al. Variation in a surface-exposed region of the Mycoplasma pneumoniae P40 protein as a consequence of homologous DNA recombination between RepMP5 elements. Microbiology 2011; 157(2): 473-83.
62. Spuesens EBM, Hoogenboezem T, Sluijter M, Hartwig NG, van Rossum AMC, Vink C. Macrolide resistance determination and molecular typing of Mycoplasma pneumoniae by pyrosequencing. J Microbiol Methods 2010; 82(3): 214-22.
63. Pereyre S, Renaudin H, Charron A, Bebear C. Clonal spread of Mycoplasma pneumoniae in primary school, Bordeaux, France. Emerg Infect Dis 2012; 18.
64. Okazaki N, Narita M, Yamada S, et al. Characteristics of macrolide-resistant Mycoplasma pneumoniae strains isolated from patients and induced with erythromycin in vitro. Microbiol Immunol 2001; 45(8): 617-20.
65. Niitu Y, Sumio H, Tomiko S, Hideo K, Shigeo K, Masahiro H. Resistance of Mycoplasma pneumoniae to erythromycin and other antibiotics. J Pediatr 1970; 76(3): 438-43.
66. Stopler T, Gerichter CB, Branski D. Antibiotic-resistant mutants of Mycoplasma pneumoniae. Isr J Med Sci 1980; 16(3): 169-73.
67. Morozumi M, Hasegawa K, Kobayashi R, et al. Emergence of macrolide-resistant Mycoplasma pneumoniae with a 23S rRNA gene mutation. Antimicrob Agents Chemother 2005; 49(6): 2302.
68. Matsuoka M, Narita M, Okazaki N, et al. Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan. Antimicrob Agents Chemother 2004; 48(12): 4624.
69. Suzuki S, Yamazaki T, Narita M, et al. Clinical evaluation of macrolide-resistant Mycoplasma pneumoniae. Antimicrob Agents Chemother 2006; 50(2): 709-12.
70. Peuchant O, Menard A, Renaudin H, et al. Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis. J Antimicrob Chemother 2009; 64(1): 52-8.
71. Dumke R, von Baum H, Luck PC, Jacobs E. Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in Germany. Clin Microbiol Infect 2010; 16(6): 613-6.
72. Chironna M, Sallustio A, Esposito S, et al. Emergence of macrolide-resistant strains during an outbreak of Mycoplasma pneumoniae infections in children. J Antimicrob Chemother 2011; 66(4): 734-7.
73. Liu Y, Ye X, Zhang H, et al. Characterization of macrolide resistance in Mycoplasma pneumoniae isolated from children in Shanghai, China. Diagn Microbiol Infect Dis 2010; 67(4): 355-8.
74. Averbuch D, Hidalgo-Grass C, Moses AE, Engelhard D, Nir-Paz R. Macrolide resistance in Mycoplasma pneumoniae, Israel, 2010. Emerg Infect Dis 2011; 17(6): 1079-82.
75. Critchley IA, Jones ME, Heinze PD, et al. In vitro activity of levofloxacin against contemporary clinical isolates of Legionella pneumophila, Mycoplasma pneumoniae and Chlamydia pneumoniae from North America and Europe. Clin Microbiol Infect 2002; 8(4): 214-21.
76. Atkinson TP, Boppana S, Theos A, Clements LS, Li X, Waites K. Stevens-Johnson Syndrome in a boy with macrolide-resistant Mycoplasma pneumoniae pneumonia. Pediatrics 2011; 127(6): e1605-e1609.
77. Li X, Atkinson TP, Hagood J, Makris C, Duffy LB, Waites KB. Emerging macrolide resistance in Mycoplasma pneumoniae in children: detection and characterization of resistant isolates. Pediatr Infect Dis J 2009; 28(8).
78. Hicks LA, Suda KJ, Roberts RM, Hunkler R, Taylor TH, Jr., Danziger LH. Antimicrobial prescription data reveal wide geographic variability in antimicrobial use in the United States, 2009. Abstracts: Antibacterial Agents and Resistance; 2010; 2010.
79. Hyde TB, Gay K, Stephens DS, et al. Macrolide resistance among invasive Streptococcus pneumoniae isolates. JAMA (Chicago, Ill) 2001; 286(15): 1857.
80. Bebear C, Pereyre S, Peuchant O. Mycoplasma pneumoniae: susceptibility and resistance to antibiotics. Future Microbiology 2011; 6(4): 423-31.